BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medical Diagnostic

Mayo Clinic Laboratories and Lucence Join Forces to Enhance Cancer Diagnostics Across U.S. and Asia

Mayo Clinic Laboratories, a global leader in advanced laboratory testing, and Lucence, a pioneering molecular diagnostics company, announced a strategic co...

January 27, 2025 | News

Shandong Cancer Hospital Treats 100 Patients with Accuray’s Tomo® C System, Advancing Precision Radiotherapy in China

Accuray Incorporated announced that Shandong Cancer Hospital and Institute has achieved a milestone with the completion of treatment for 100 patients ...

January 24, 2025 | News

Pearl Partners with Australia’s Centaur to Advance Dental AI Across Asia Pacific and Middle East

Pearl, the global leader in dental AI solutions, announced a strategic partnership with Centaur, Australia’s leading dental practice management ...

January 22, 2025 | News

Ascletis Pharma Reports Promising Results for ASC30 Oral Tablet in Obesity Treatment

ASC30 oral tablet demonstrated dose-proportional pharmacokinetic (PK) properties and a long half-life (t1/2) up to 60 hours in the single ascending dose ...

January 22, 2025 | News

HKUST Researchers Develop World's Smallest Multifunctional Biomedical Robot for Precision Diagnosis and Treatment

Researchers from the School of Engineering of the Hong Kong University of Science and Technology (HKUST) have successfully developed the world's ...

January 21, 2025 | News

AstraZeneca and Daiichi Sankyo’s DATROWAY Secures First US Approval for HR-Positive, HER2-Negative Breast Cancer

First approval in the US for AstraZeneca and Daiichi Sankyo’s DATROWAY based on TROPION-Breast01 results showing 37% reduction in the risk of d...

January 20, 2025 | News

Guangzhou Fermion Partners with Simcere to Advance Clinical-Stage SSTR4 Agonist for Pain Management

Guangzhou Fermion Technology Co., Ltd. and Simcere Pharmaceutical Group Limited have announced a partnership to develop a clinical-stage pain treatment ass...

January 20, 2025 | News

Nextbiomedical Secures FDA IDE Approval for U.S. Clinical Trial of Nexsphere-F™ in Knee Osteoarthritis

NEXTBIOMEDICAL CO., LTD, a KOSDAQ-listed innovative medical device company in South Korea, proudly announced that it has received Investigational Devi...

January 16, 2025 | News

Advanced Genomics APAC and Cancer Precision Medicine Partner to Launch GALEAS™ Bladder Cancer Screening Test in Japan

Advanced Genomics APAC Co., Ltd. (hereinafter referred to as "Advanced Genomics APAC," headquartered in Taiwan, Managing Director: Andy Chang) i...

January 14, 2025 | News

Menarini Group Partners with Insilico Medicine on AI-Discovered Oncology Asset in $550M Licensing Deal

This is the second asset Menarini Group has inlicensed from Insilico Medicine which was discovered through their generative AI platform, si...

January 13, 2025 | News

Eyebright Medical Secures NMPA Approval for Loong Crystal PR, a Cutting-Edge Solution for Myopia Correction

Eyebright Medical Technology (Beijing) Co., Ltd. ("Eyebright Medical", the "Company", Stock Code: 688050.SH, together with its subsidiaries coll...

January 08, 2025 | News

Inogen Secures FDA Clearance for SIMEOX 200 Airway Clearance Device

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced tha...

January 02, 2025 | News

Alphamab Oncology Gains Approval for Phase III Clinical Study of Anti-HER2 ADC JSKN003 in Platinum-Resistant Ovarian Cancer

Alphamab Oncology (stock code: 9966.HK) announced that anti-HER2 bispecific antibody-drug conjugate (ADC) JSKN003 has received approval from the Center for...

December 30, 2024 | News

Huadong Medicine and SynerK PharmaTech Forge Strategic Alliance to Develop siRNA Drug for Hypertension

Hangzhou Sino-US Huadong Medicine Co., Ltd. (hereinafter referred to as "Huadong Medicine"), a wholly-owned subsidiary of Huadong Medicine Co., Ltd. (SZ.00...

December 30, 2024 | News

Stay Connected